-Reuters
Why Is Brain Cancer Focused TransCode Therapeutics Stock Trading 300% Higher Today?
TransCode Therapeutics Inc (NASDAQ: RNAZ) shares are trading higher after the company announced results with its lead therapeutic candidate, TTX-MC138, in murine models bearing human glioblastoma